Literature DB >> 11821792

Therapeutic value of lymph node dissection and the clinical outcome for patients with gastric cancer.

Yoshihiko Maehara1, Yoshihiro Kakeji, Tadashi Koga, Yasunori Emi, Hideo Baba, Kohei Akazawa, Keizo Sugimachi.   

Abstract

BACKGROUND: While the incidence of gastric cancer differs greatly between Japan and other countries, both diagnostic and treatment modalities for patients with gastric cancer have improved in Japan. What follows is an overview of the effects of lymph node dissection for such patients.
METHODS: We analyzed data on 2152 Japanese men and women with gastric cancer who underwent surgical resection from 1965 to 1995 at Kyushu University in Fukuoka, Japan. We focused on time trends of surgical management, including lymph node dissection and postoperative outcome.
RESULTS: In all cases of gastric cancer, the rate of early gastric cancer increased from 18% in the first 6-year period to 57% in the last 5-year period. Extensive lymph node dissections (D2 and D3) were performed more frequently in recent years. Due to early identification of the cancer and upgraded perioperative care, both postoperative morbidity and mortality rates 30 days after surgery have decreased greatly, even in aged patients.
CONCLUSIONS: Early tumor detection, standardized surgical treatment, including routine lymph node dissection, and improved perioperative management have led to increased survival time among patients with this malignancy.

Entities:  

Mesh:

Year:  2002        PMID: 11821792     DOI: 10.1067/msy.2002.119309

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  9 in total

1.  Retrospective analysis of the results of strip biopsies to determine the indication for endoscopic submucosal dissection for early gastric cancer.

Authors:  Hiroki Nakamura; Hideo Yanai; Masaaki Satake; Takeshi Okamoto; Jun Nishikawa; Isao Sakaida; Toyokazu Kawano; Keisuke Matsusaki; Osamu Miura
Journal:  J Gastrointest Cancer       Date:  2009-02-24

2.  How does epidemiological and clinicopathological features affect survival after gastrectomy for gastric cancer patients-single Egyptian center experience.

Authors:  Ehab El Hanafy; Ayman El Nakeeb; Helmy Ezzat; Emad Hamdy; Ehab Atif; Tharwat Kandil; Amgad Fouad; Mohamed Abdel Wahab; Ahmed Monier
Journal:  World J Gastrointest Surg       Date:  2016-06-27

Review 3.  Gastric adenocarcinoma: review and considerations for future directions.

Authors:  Bryan J Dicken; David L Bigam; Carol Cass; John R Mackey; Anil A Joy; Stewart M Hamilton
Journal:  Ann Surg       Date:  2005-01       Impact factor: 12.969

4.  D2 vs D2 Plus Para-aortic Lymph Node Dissection for Advanced Gastric Cancer.

Authors:  Mehmet Mahir Ozmen; Baris Zulfikaroglu; Fusun Ozmen; Munevver Moran; Necdet Ozalp; Selda Seckin
Journal:  Turk J Surg       Date:  2020-12-08

5.  Positive VEGF immunostaining independently predicts poor prognosis in curatively resected gastric cancer patients: results of a study assessing a panel of angiogenic markers.

Authors:  Oscar Vidal; Antonio Soriano-Izquierdo; Manuel Pera; José I Elizalde; Antonio Palacín; Antoni Castells; Josep M Piqué; Alain Volant; Jean P Metges
Journal:  J Gastrointest Surg       Date:  2007-10-31       Impact factor: 3.452

6.  The distance of proximal resection margin dose not significantly influence on the prognosis of gastric cancer patients after curative resection.

Authors:  Min Gyu Kim; Ju-Hee Lee; Tae Kyung Ha; Sung Joon Kwon
Journal:  Ann Surg Treat Res       Date:  2014-10-24       Impact factor: 1.859

Review 7.  Epidemiology of gastric cancer and risk factors.

Authors:  Ottavia Cavatorta; Serena Scida; Chiara Miraglia; Alberto Barchi; Antonio Nouvenne; Gioacchino Leandro; Tiziana Meschi; Gian Luigi De' Angelis; Francesco Di Mario
Journal:  Acta Biomed       Date:  2018-12-17

8.  Clinical Application of Indocyanine Green Fluorescence Technology in Laparoscopic Radical Gastrectomy.

Authors:  Meng Wei; Yize Liang; Limei Wang; Zhen Li; Yuanyuan Chen; Zhibo Yan; Danping Sun; Yadi Huang; Xin Zhong; Peng Liu; Wenbin Yu
Journal:  Front Oncol       Date:  2022-03-04       Impact factor: 6.244

9.  Loss of the coxsackie and adenovirus receptor contributes to gastric cancer progression.

Authors:  M Anders; M Vieth; C Röcken; M Ebert; M Pross; S Gretschel; P M Schlag; B Wiedenmann; W Kemmner; M Höcker
Journal:  Br J Cancer       Date:  2009-01-13       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.